In melanoma cell lines, PTEN loss has been shown to mediate host immune response to cancer through upregulation of immunosuppressive cytokines IL-6, IL-10, and VEGF, as well as through the regulation of PDL-1 expression [9,14]. The gene discussed is VEGFA; the disease is melanoma.